Howard Marks
Oaktree Capital Management
Howard Marks ALVOTECH SA -27 stake
total: 853
Oaktree Capital Management ALVOW trades
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2022 Q2
- Held for:
- 17 quarters
- Latest activity:
- 2022 Q2
According to 2026 Q2 report, Howard Marks holds 4,666,667 ALVOTECH SA -27 (ALVOW) shares with a market value of roughly $1.07M accounting for 0.02% of the overall portfolio. To date, the estimated cost basis is nearly $0.84 for "buy" trades. Oaktree Capital Management first purchased ALVOW in 2022 Q2, initially acquiring about 4.67M shares.
When did Howard Marks buy ALVOTECH SA -27 (ALVOW)?
Howard Marks first invested in ALVOTECH SA -27 (ALVOW) in 2022 Q2 at the reported quarter-end price of $0.84 per share.
What's the cost basis of Oaktree Capital Management's ALVOW stake?
The estimated cost basis for ALVOTECH SA -27 (ALVOW) stake is around $0.84 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $0.84
Howard Marks's historical trades in ALVOTECH SA -27
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q2
|
0.05%
|
4,666,667
|
$0.84
|
$3,920,000
|
new
|
+0.05%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.